Physician profile
David E Blocker
NPI 1265428700
$641.13
in general payments reported to CMS, 2019-2025
19 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2021: $94.94 · 2022: $75.08 · 2023: $51.87 · 2024: $170 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $123.08 | 2024 | Iovera |
| Musculoskeletal Transplant Foundation INC. | $111.06 | 2020-2022 | |
| Exact Sciences Corporation | $58.50 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Smith+Nephew, INC. | $46.89 | 2020-2024 | Collagenase Santyl |
| Solventum Corporation | $39.29 | 2024-2025 | Activ.A.C. |
| Organogenesis INC. | $36.29 | 2020-2021 | |
| Kerecis Limited | $22.28 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbott Laboratories | $21.40 | 2022 | |
| Corium, LLC | $20.91 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.91 | 2021 | |
| Kci USA, INC. | $19.77 | 2021 | |
| Urgo Medical North America, LLC | $19.05 | 2025 | Urgoclean Ag |
| Paratek Pharmaceuticals, INC. | $17.10 | 2024 | Nuzyra |
| Next Science LLC | $16.31 | 2023 | Blastx, Surgx, Xperience |
| Idorsia Pharmaceuticals US INC | $15.86 | 2023 | Quviviq |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $14.45 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $13.15 | 2022 | |
| Dexcom, INC. | $13.09 | 2021 | |
| Novo Nordisk INC | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Blocker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.